Hosomi Y - Search Results

1

Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Tozuka T, Noro R, Mizutani H, Kurimoto F, Hakozaki T, Hisakane K, Naito T, Takahashi S, Taniuchi N, Yajima C, Hosomi Y, Hirose T, Minegishi Y, Okano T, Kamio K, Yamaguchi T, Seike M; East Japan Chesters Group. Tozuka T, et al. Among authors: hosomi y. Lung Cancer. 2024 May;191:107540. doi: 10.1016/j.lungcan.2024.107540. Epub 2024 Mar 24. Lung Cancer. 2024. PMID: 38614069

2

The promoter region of the human BUBR1 gene and its expression analysis in lung cancer.

Seike M, Gemma A, Hosoya Y, Hosomi Y, Okano T, Kurimoto F, Uematsu K, Takenaka K, Yoshimura A, Shibuya M, Ui-Tei K, Kudoh S. Seike M, et al. Among authors: hosomi y. Lung Cancer. 2002 Dec;38(3):229-34. doi: 10.1016/s0169-5002(02)00218-0. Lung Cancer. 2002. PMID: 12445743

3

Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.

Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S. Yoshimura A, et al. Among authors: hosomi y. Genes Chromosomes Cancer. 2003 Jun;37(2):159-64. doi: 10.1002/gcc.10205. Genes Chromosomes Cancer. 2003. PMID: 12696064

4

Somatic mutation of the Caspase-5 gene in human lung cancer.

Hosomi Y, Gemma A, Hosoya Y, Nara M, Okano T, Takenaka K, Yoshimura A, Koizumi K, Shimizu K, Kudoh S. Hosomi Y, et al. Int J Mol Med. 2003 Oct;12(4):443-6. doi: 10.3892/ijmm.12.4.443. Int J Mol Med. 2003. PMID: 12964016

5

Reduced transcription of the RB2/p130 gene in human lung cancer.

Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S. Xue Jun H, et al. Among authors: hosomi y. Mol Carcinog. 2003 Nov;38(3):124-9. doi: 10.1002/mc.10152. Mol Carcinog. 2003. PMID: 14587097

6

Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S. Okano T, et al. Among authors: hosomi y. Oncol Rep. 2006 Mar;15(3):545-9. Oncol Rep. 2006. PMID: 16465410

7

Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.

Gemma A, Seike M, Kosaihira S, Minegishi Y, Noro R, Nara M, Hosomi Y, Okano T, Kokubo Y, Yoshimura A, Shibuya M, Kudoh S. Gemma A, et al. Among authors: hosomi y. Anticancer Res. 2006 Jul-Aug;26(4B):3083-7. Anticancer Res. 2006. PMID: 16886638 Free article. Clinical Trial.

8

S-1 is an active anticancer agent for advanced thymic carcinoma.

Okuma Y, Shimokawa T, Takagi Y, Hosomi Y, Iguchi M, Okamura T, Shibuya M. Okuma Y, et al. Among authors: hosomi y. Lung Cancer. 2010 Dec;70(3):357-63. doi: 10.1016/j.lungcan.2010.09.004. Epub 2010 Oct 15. Lung Cancer. 2010. PMID: 20951466

9

Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis.

Takenaka K, Gemma A, Yoshimura A, Hosoya Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, Fukuda Y, Uematsu K, Shimizu K, Kudoh S. Takenaka K, et al. Among authors: hosomi y. Mol Med Rep. 2009 Jan-Feb;2(1):73-80. doi: 10.3892/mmr_00000064. Mol Med Rep. 2009. PMID: 21475793

10

Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity.

Okuma Y, Hosomi Y, Takagi Y, Iguchi M, Okamura T, Shibuya M. Okuma Y, et al. Among authors: hosomi y. Lung Cancer. 2011 Dec;74(3):492-6. doi: 10.1016/j.lungcan.2011.05.013. Epub 2011 Jun 12. Lung Cancer. 2011. PMID: 21665316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters